PROCEPT BioRobotics news

Company allegedly used undisclosed discount programs to artificially inflate handpiece sales, created excess field inventory exceeding 10,000 units, and issued unachievable 2025 guidance.

The company is accused of securities fraud involving material misstatements about business operations and financial condition. Undisclosed discount programs artificially inflated sales figures, leading to excess inventory accumulation. Stock declined 13.35%, 9.74%, and 15.12% on three separate negative announcements, resulting in significant investor losses.

The company is the subject of a securities class action lawsuit alleging fraudulent misrepresentation regarding sales practices and revenue reporting. The allegations of undisclosed discount programs artificially inflating sales figures and misleading investor communications represent serious legal and reputational risks.

The company is accused of deliberately misleading investors about handpiece sales through undisclosed bulk discount programs designed to artificially inflate revenues and pull forward sales. Multiple earnings misses, a 48% stock price decline, and the elimination of the discount program indicate serious operational and governance issues that resulted in substantial investor losses.

The company is the subject of a securities class action lawsuit alleging materially false and misleading statements about sales figures, undisclosed discount programs that artificially inflated revenues, excess inventory of over 10,000 units, and inability to achieve stated guidance. These allegations indicate significant operational and financial misconduct.

The company is accused of making materially false and misleading statements about sales and revenues through an undisclosed discount program that artificially inflated numbers, created excessive inventory, and resulted in failure to meet stated guidance. These allegations indicate serious accounting and disclosure violations with significant investor harm.

The company is accused of making false and misleading statements to the market, artificially inflating revenue through aggressive discounting practices, and overstating asset utilization. These allegations of securities fraud and investor losses warrant a negative sentiment rating.

The company is accused of deliberately misleading investors about sales performance through undisclosed discount programs designed to artificially inflate quarterly results. Multiple earnings misses, a 48% stock price decline, and revelations of excess customer inventory (10,000+ units) indicate serious operational and transparency issues that resulted in substantial investor losses.

Company failed to disclose material inventory issues where handpiece sales exceeded procedures by over 10,000 cumulative units since Q1 2023. This led to a significant 18% stock price decline over two days and a nearly 30% sequential drop in quarterly sales, resulting in the company missing annual revenue guidance by tens of millions of dollars. The undisclosed inventory glut represents a material breach of investor trust and securities law violations.

The company is the subject of a securities class action lawsuit alleging material misstatements about sales figures, undisclosed discount programs that artificially inflated revenues, excess inventory of over 10,000 units, and inability to achieve stated guidance. These allegations indicate significant operational and financial misconduct.

The company is the subject of a securities class action lawsuit alleging material misstatements about sales practices, artificially inflated revenues through undisclosed discount programs, excess inventory accumulation exceeding 10,000 units, and unachievable financial guidance. These allegations indicate significant operational and financial misconduct that harmed investors.

The company is the subject of a securities fraud class action alleging material misstatements about sales figures through undisclosed discount programs. Stock experienced significant declines (16%, 10%, and 18%) following earnings announcements revealing handpiece sales deterioration, missed guidance, and discovery of over 10,000 excess inventory units.

The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding undisclosed discount programs that artificially inflated sales figures, created unsustainable inventory levels exceeding 10,000 excess units, and rendered forward guidance unachievable. These allegations indicate significant operational and financial misconduct.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding sales practices, revenue inflation through undisclosed discount programs, and excessive field inventory. These allegations suggest fraudulent business practices and financial misrepresentation that caused investor losses.

The company is accused of making materially false and misleading statements, using undisclosed discount programs to artificially inflate sales, accumulating excess inventory of 10,000+ units, missing earnings guidance, and experiencing significant stock price declines (16%, 10%, and 18%) following successive earnings announcements revealing operational and financial deterioration.

The company is accused of making materially false and misleading statements about sales and revenues through undisclosed discount programs that artificially inflated figures, created excess inventory, and lacked a reasonable basis for guidance. These allegations indicate significant corporate misconduct and financial misrepresentation.

The company is the subject of a securities class action lawsuit alleging material misrepresentations regarding sales practices and revenue recognition. The allegations suggest deliberate concealment of discount programs that artificially inflated reported sales figures, which constitutes securities fraud and indicates serious corporate governance and disclosure failures.

CEO's significant insider purchase of ~$498,000 in shares signals management confidence in the company's direction. The purchase follows Q2 sales growth of 19% and a strategic reorganization led by Wood. While the stock is down 48% year-over-year and the company remains unprofitable, insider buying is historically predictive of share price appreciation within 30 days and demonstrates management's conviction in long-term profitability prospects.

The company is facing a securities fraud class action lawsuit alleging material misstatements about product demand and undisclosed discount programs that artificially inflated sales figures. The stock declined over 18% when the truth was revealed, indicating significant investor losses and reputational damage.

The company is accused of making materially false and misleading statements about sales and revenues through an undisclosed discount program that artificially inflated figures. The lawsuit alleges significant operational risks, inventory glut of over 10,000 excess units, and inability to achieve stated guidance, indicating serious financial and reputational harm.

The company is facing a securities class action lawsuit alleging material misstatements and omissions regarding handpiece sales and inventory levels. The allegations suggest management failed to disclose significant operational issues including excess inventory accumulation and inflated sales figures, which led to missed revenue guidance. These are serious violations of federal securities laws that resulted in investor losses.

Company is accused of fraudulent sales practices, using undisclosed discount programs to artificially inflate reported sales and revenues, resulting in investor losses during the Class Period.

Company used undisclosed aggressive discount programs that artificially inflated handpiece unit sales and revenues, created over 10,000 excess units of field inventory, and made 2025 guidance that lacked reasonable factual basis.

The company is accused of making materially false and misleading statements about sales practices, artificially inflating revenues through undisclosed discount programs, creating excess inventory, and providing unrealistic guidance. These allegations indicate significant corporate misconduct and financial misrepresentation.

The company is accused of making materially false and misleading statements about sales and operations through undisclosed discount programs that artificially inflated revenues. Multiple earnings announcements revealed significant misses versus guidance, and the stock declined 16%, 10%, and 18% respectively following three separate announcements. The company also had to reduce guidance and admitted to poor inventory management practices.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding sales figures, undisclosed discount programs that artificially inflated revenues, creation of excess inventory, and unachievable guidance. These allegations indicate significant corporate governance and disclosure failures that caused investor harm.

The company faces serious allegations of issuing materially false and misleading statements, utilizing undisclosed discount programs to artificially inflate sales and revenues, creating excess inventory of over 10,000 units, and failing to disclose material operational and financial risks. These allegations suggest fraudulent business practices and potential significant financial harm to investors.

The company is accused of making materially false and misleading statements about handpiece unit sales and revenues through an undisclosed discount program that artificially inflated sales, created excess inventory of over 10,000 units, and failed to disclose material operational and financial risks. The company was unable to achieve its stated 2025 guidance, indicating significant business deterioration and investor harm.

Alleged use of undisclosed aggressive discount programs that artificially inflated handpiece sales and revenues, created excess field inventory exceeding 10,000 units, and made 2025 guidance unachievable.

The company is the subject of a securities class action lawsuit alleging material misrepresentations and omissions regarding business operations and financial stability, resulting in artificially inflated stock prices and significant investor losses.

The company is accused of making materially false and misleading statements about sales practices, artificially inflating revenues through undisclosed discount programs, creating excess inventory, and issuing unrealistic guidance. Stock prices fell 16%, 10%, and 18% following successive earnings announcements revealing the issues.

The company faces an ongoing securities fraud investigation, reported larger-than-expected losses, cut revenue guidance significantly, and experienced a 15.12% stock price decline following earnings disclosure. These factors indicate serious operational and legal challenges.

The company faces a securities fraud investigation following disappointing earnings results, significant revenue guidance cuts, and substantial stock price decline. The investigation suggests potential violations of federal securities laws, indicating serious concerns about the company's financial disclosures and business performance.

The company is under investigation for potential securities law violations involving false or misleading statements. Additionally, it reported significantly lower-than-expected quarterly revenue, cut full-year guidance substantially, and experienced a 15.1% stock price decline following the announcement.

Company reported quarterly revenue significantly below analyst expectations, cut full-year 2026 revenue guidance substantially, and is now subject to a securities fraud investigation. Stock price declined 15.12% following the announcement, indicating significant investor concern about potential mismanagement or misleading statements.

Company is subject to a securities class action lawsuit with an upcoming September 22 deadline, indicating investor claims of misconduct or material misstatements.

Company is subject to a securities class action lawsuit with an upcoming September 22 deadline, indicating alleged investor harm and legal disputes.

Company is defendant in securities class action lawsuit filed by Rosen Law Firm, indicating alleged securities violations and investor losses.

Company is subject to a securities class action lawsuit with an upcoming lead plaintiff deadline, indicating alleged securities violations.

Subject of a securities class action lawsuit filed by Rosen Law Firm, indicating alleged misconduct or misrepresentation to investors.

The company is mentioned as having an ongoing securities class action lawsuit with an important deadline, indicating alleged securities violations and investor losses.

Company is subject to securities class action lawsuit (details partially provided in article), indicating alleged investor harm and potential securities violations.

Company is defendant in securities class action lawsuit; specific allegations not detailed in provided excerpt but included in class action notice.

Subject of a securities class action lawsuit with a lead plaintiff deadline of September 22, 2026, indicating alleged investor harm and potential disclosure violations.

Company is subject to investigation and class action lawsuit by Pomerantz LLP for alleged securities fraud and unlawful business practices, indicating potential investor losses and legal exposure.

Company is subject to a securities class action with an important deadline, indicating allegations of investor harm and potential securities violations.

Class action lawsuit has been filed against the company, though specific allegations are not detailed in the article. The mere filing of such litigation indicates investor concerns and potential securities violations.

Company is mentioned as subject to a securities class action, though specific allegations are not detailed in the provided excerpt, indicating legal and investor concerns.

Subject of a pending class action lawsuit with a lead plaintiff deadline of September 22, 2026, indicating allegations of securities violations.

The company is subject to a pending class action lawsuit with a lead plaintiff deadline of September 22, 2026, indicating similar allegations of securities violations and investor harm.

Company faces securities fraud allegations related to undisclosed inventory issues, resulting in approximately 18% stock decline, indicating material misrepresentation to investors.

Company and certain executives face class action lawsuit alleging they made false and/or misleading statements to investors, indicating potential securities fraud and breach of investor trust.